I have finalised the demo for the ICH-GCP E6 R3 refresher course. Overall, I liked the content and the interface. I also want to thank Whitehall Train...
About
The Pharmaceutical Medicine Learning Path prepares professionals to understand key principles across the pharmaceutical and clinical drug development lifecycle. It covers pharmaceutical medicine, clinical phases of drug development, general pharmacology, toxicology, clinical trial design, and clinical trial endpoints.
Participants will develop the knowledge and skills to support scientifically sound, ethical, and regulatory-compliant drug development and clinical research.
Courses Included

Understanding the fundamental principles of pharmaceutical medicine and its role in the development, evaluation, and safe use of medicinal products.

Understanding the fundamental principles of pharmacology, including drug mechanisms of action, pharmacokinetics, pharmacodynamics, therapeutic effects, and factors influencing the safe and effective use of medicines.

Understanding the key phases of clinical drug development, from early safety studies through post-marketing evaluation.

Understanding clinical trial endpoints and their role in evaluating treatment safety and efficacy.

Understanding toxicology principles for evaluating drug safety and potential risks.

Understanding key principles of clinical trial design, including study objectives, methodology, and bias control.
Our Certified Customers
Learner Rating & Reviews
Frequently Asked Questions
- Pharmaceutical medicine and clinical research professionals
- Clinical development and drug development professionals
- Professionals involved in pharmacology, toxicology, and clinical trials
- Healthcare and life sciences professionals seeking knowledge of pharmaceutical medicine
Upon completion of this learning path, participants will be able to apply key principles of pharmaceutical medicine, understand the clinical phases of drug development, explain core pharmacology and toxicology concepts, contribute to sound clinical trial design, and evaluate appropriate clinical trial endpoints while supporting patient safety, scientific integrity, and regulatory compliance.







